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Clonally expanded human airway smooth muscle
cells exhibit morphological and functional
heterogeneity
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Abstract
Background: Mesenchyme-derived airway cell populations including airway smooth muscle (ASM) cells, fibroblasts
and myofibroblasts play key roles in the pathogenesis of airway inflammation and remodeling. Phenotypic and
functional characterisation of these cell populations are confounded by their heterogeneity in vitro. It is unclear
which mechanisms underlie the creation of these different sub-populations.
The study objectives were to investigate whether ASM cells are capable of clonal expansion and if so (i) what
proportion possess this capability and (ii) do clonal populations exhibit variation in terms of morphology,
phenotype, proliferation rates and pro-relaxant or pro-contractile signaling pathways.
Methods: Early passage human ASM cells were subjected to single-cell cloning and their doubling time was
recorded. Immunocytochemistry was performed to assess localization and levels of markers previously reported
to be specifically associated with smooth muscle or fibroblasts. Finally functional assays were used to reveal
differences between clonal populations specifically assessing mitogen-induced proliferation and pro-relaxant
and pro-contractile signaling pathways.
Results: Our studies provide evidence that a high proportion (58%) of single cells present within early passage
human ASM cell cultures have the potential to create expanded cell populations. Despite being clonally-originated,
morphological heterogeneity was still evident within these clonal populations as assessed by the range in expression
of markers associated with smooth muscle cells. Functional diversity was observed between clonal populations with
10 μM isoproterenol-induced cyclic AMP responses ranging from 1.4 - 5.4 fold cf basal and bradykinin-induced inositol
phosphate from 1.8 - 5.2 fold cf basal.
Conclusion: In summary we show for the first time that primary human ASM cells are capable of clonal expansion and
that the resulting clonal populations themselves exhibit phenotypic plasticity.
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Background
Human airway smooth muscle (ASM) cells are key players
in the development, orchestration and perpetuation of
asthma pathology [1]. In addition to forming the muscle
mass which causes bronchospasm in asthma exacerba-
tions, human ASM cells also mediate inflammation via
cytokine release [1]. Increased ASM mass is a feature of
the airway remodeling seen in many individuals with
chronic asthma, where it is associated with disease severity
[2-4]. Increased ASM area has also been shown to correl-
ate with airflow obstruction (likely due to a combination
of increased contractility and decreased lumen size) [5].
The mechanisms behind the increase in ASM mass in
asthma may involve hyperplasia, hypertrophy, decreased
apoptosis, altered migration, increased recruitment of fibro-
cytes or increased differentiation of mesenchymal stem
cells or via epithelial-mesenchymal differentiation, or in-
deed a combination of any or all of the above [6]. Whilst
in vivo little is known of the clinical relevance of these
mechanisms, in vitro the ASM cell signaling pathways key
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to these events have been extensively researched and many
pro-proliferative, pro-apoptotic and pro-migratory media-
tors identified [7]. In addition to these molecules, recent
evidence demonstrates the ability of bronchoconstriction it-
self to induce airway remodeling both in guinea-pigs [8]
and humans [9].
It is also important to consider how phenotypic switching
of ASM cells could impact on ASM mass. Phenotypic
switching or phenotype plasticity refers to the change in an
ASM cell classically between a “contractile” (or even
“hypercontractile”) and “synthetic” or “proliferative” state
[10]. In vitro phenotypic plasticity has been demonstrated as
being tightly regulated: growth factors, fibronectin, collagen
type I, integrins and adhesion molecules are observed to in-
duce a synthetic phenotype whereas serum deprivation,
Transforming Growth Factor β (TGF-β) and insulin are ob-
served to induce a contractile phenotype (see [10]).
Given the phenotypic heterogeneity which ASM cells
can exhibit in vitro [11], we aimed to investigate the
clonal origin of populations of cells in ASM in order to
determine whether single cells were capable of clonal ex-
pansion and also to define how different resulting clones
might be from each other and their parental cell in
terms of morphology and function. Functional differ-
ences were investigated by assessing pro-relaxant and
pro-contractile second messenger signaling pathways,
namely β2-adrenoceptor-mediated cyclic AMP formation
and bradykinin B1 and histamine H1 receptor-mediated
inositol phosphate production respectively.
This is the first study to show that a significant pro-
portion of single cells present within early human ASM
cell cultures have the potential to create expanded cell
populations. These clonal cell populations were observed
to be morphologically and functionally diverse.
Methods
Human airway smooth muscle cell culture
Human airway smooth muscle (ASM) cells were prepared
as previously described via enzymatic dispersion from four
individuals undergoing thoracotomy [12]. Ethical approval
was obtained from the local Nottingham ethical research
committee (EC00/165). Cells were cultured in Dulbecco’s
modified Eagles media (DMEM) containing 10% fetal calf
serum and glutamine (2 mM) and incubated at 37°C in 5%
CO2. Cells isolated and cultured in this way have been ex-
tensively characterised and shown to retain many of the
phenotypic properties of freshly isolated airway smooth
muscle cells [13-15]. Cells expanded for use in the signal-
ing assays originated from one donor.
Single cell sorting via Fluorescence-activated cell sorting
(FACS)
Early passage (passage 2–4) human ASM cells were grown
to ~90% confluency and cultured in 0.5% foetal calf serum
(FCS) supplemented DMEM medium for 24 hours. Cells
were then exposed to trypsin to place the cells in suspen-
sion, pelleted, resuspended in PBS and then subjected to
single cell sorting in 96 well culture plates using Coulter
Epics Altra Hypersort fluorescence-activated cell sorter
system. Using a forward versus side scatter plot the cell
sort gating criteria ensured that only cells with similar
morphological characteristics were used in this process.
Cells were singly-sorted directly into the 96 well plate with
each well containing DMEM medium supplemented with
20% FCS and glutamine. Single cell occupancy in each
well of 96 well plates was confirmed by thorough micro-
scopic examination and those wells with no cells or more
than one cell were marked and not included any further
in the experiment. With the exception of the increased
percentage of FCS (20%), cells were thereafter cultured
using the standard techniques specified above. Growth
medium was replaced 7 days after plating and then after-
wards every 2 days. As the cells achieved confluency in
one well of the 96 well plate (surface area: 0.3 cm2), they
were trypsinised and subcultured into one well of a 24
well plate (surface area: 1.9 cm2) and at this stage were
cultured using standard techniques for human ASM cells
(DMEM medium supplemented with 10% FCS and 2%
glutamine). Once confluency was achieved in one well of
a 24 well plate, the cells were subcultured into one well of
a 6 well plate (surface area: 9.4 cm2) and once this well
contained a confluent monolayer cells were subcultured
into a 25 cm2 culture flask (T25). Throughout this time-
course the times at which confluency was achieved in the
diverse vessel sizes was recorded and hence doubling
times could be calculated. The values expressed were
mean ± Standard Error Mean (SEM) of the doubling time
recorded for cells that proliferated.
Single cell sorting via serial dilution
Early passage (2–4) human ASM cells were cultured
to ~90% confluence then grown in medium containing 0.5%
FCS then exposed to trypsin to place the cells in suspen-
sion. The total cell count in the suspension was determined
using a haemocytometer prior to the cell suspension being
subjected to serial dilutions until calculations predicted that
one cell should be present per 250 μl of DMEM medium
(supplemented with 20% FCS and glutamine). Each 250 μl
sample (containing one cell according to calculations) was
placed into a separate well of a 96 well plate and incubated
at 37C, 5% CO2. Single cell occupancy in each well of 96
well plates was again confirmed by thorough microscopic
examination and those wells with no cells or more than
one cell were not included any further in the experiment.
Cells were then cultured and doubling times assessed
exactly as described above (Single Cell Sorting via FACS).
For some analyses, clonal cell populations were grouped
based on the time required for the clones to achieve
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confluency in culture plates in initial experiments: I) Fast
Growing clonal populations: Populations achieving con-
fluency in a 25 cm2 tissue culture flask in less than 45 days
and II) Slow Growing clonal populations: Populations
achieving confluency in a 25 cm2 tissue culture flask in
45 days or more.
[3H]-Thymidine incorporation in human ASM cells
[3H]-Thymidine incorporation in human ASM cells was
assessed as previously reported with minor modification
[16]. Cells were seeded at 2.5 × 104 cells/ well and grown
to subconfluence (70–90%) in 24-well plates were
washed and incubated in DMEM containing 0.1% FCS
and 2 mM glutamine for 24 h to growth arrest the cells.
Platelet derived growth factor (PDGF-BB) at a range of
concentrations (20 fg/ml to 20 ng/ml) was added and
present in the well for a total of 24 h with [3H]-thymi-
dine (1 μCi/well) being added and present for the final
16 h of the incubation. At the end of this period, the
supernatant was aspirated, and the cells were washed
twice with PBS before being fixed with methanol-glacial
acetic acid (3:1) for at least 1 h at room temperature.
Two further washes with methanol–water (4:1) were
performed before the cells were lysed with 1 ml of 1 M
NaOH. Nine hundred microliters of the supernatant
were transferred to a scintillation vial along with 10 ml
of scintillation fluid (Packard, Meriden, CT) and counted
on a LKB scintillation counter (efficiency ∼ 30%), the re-
sults being expressed as disintegrations per minute or as
a multiple of stimulation over the control value.
Proliferation rates were expressed as mean ± SEM. Donor
and passage-matched human ASM cells (passage 9) were
referred as the ‘standard’ cell type. Four Fast Growing clonal
populations and five Slow Growing clonal populations (as
defined above) were used.
Determination of cyclic AMP accumulation in human ASM
cells
Accumulation of [3H] cyclic AMP was measured by a
modification of a previously described method [16]. In
brief, confluent monolayers of cells plated at 2.5 × 104
cells/ well in 24 well plates were labeled with [3H]aden-
ine (2 μCi/well) for 2 h in DMEM at 37°C. At the end of
this period, the cells were washed three times with 1 ml
of Hanks-HEPES buffer and allowed to rewarm to 37°C
for 20 min in the presence or absence of a range of con-
centrations of the β-adrenoceptor agonist isoproterenol
(10−9 to 10−5 M) before the reactions were terminated
by the addition of 50 μl of concentrated HCl. The cells
were then stored at −20°C. [3H] cyclic AMP was deter-
mined by column chromatography after the cells were
rethawed as previously described [16]. Aliquots of
[14C] cyclic AMP were added to each sample, and the
counts obtained from this recovery marker were used
to correct for variations in recovery from each column.
In addition, a 100 μl aliquot was taken from each well
of the plate after the reactions were stopped and counted
for tritium to correct for variations in the number of cells
per well.
Triplicate wells were counted for each condition, and
the data are expressed as fold change (compared with
basal counts). Mean data are presented (±SEM). Donor
and passage-matched human ASM cells (passage 9) were
referred as the ‘standard’ cell type.
Determination of Total [3H] Inositol Phosphate in human
ASM cells
[3H] Inositol phosphate formation was determined as
described below. Near-confluent cell monolayers in 12
well plates were incubated for 24 h at 37°C with 500 μl
of inositol-free DMEM containing [3H] myoinositol
(47 Ci/mmol) at a concentration of 4 μCi/ml. After load-
ing, cells were washed once with PBS. Inositol-free
DMEM containing 10 mM LiCl was added to each well
and the cells were incubated for 10 min at 37°C. Cells were
then stimulated with a range of concentrations of hista-
mine (10−9 to 10−4 M) or bradykinin (10−10 to 10−5 M) for
10 min at 37°C. Reactions were stopped by aspirating
medium and adding 0.8 ml of ice-cold 0.4 M perchloric
acid. A total of 0.4 ml of 0.72 N KOH/0.6 M KHCO3 was
added, and the sample was centrifuged to settle the pre-
cipitate. The supernatant was applied to 1 ml AG1-X8
(Bio-Rad, Hercules, CA) columns (100 to 200 mesh, for-
mate form), which were washed with 10 ml of 0.1 N formic
acid, and total inositol phosphates were eluted with 1.5 M
ammonium formate/0.1 N formic acid and counted. Donor
and passage-matched human ASM cells (passage 9) were
referred as the ‘standard’ cell type.
Fluorescent immunocytochemistry
Cells were cultured and immunostained using published
methods [11]. Primary antibodies and concentrations used
were: α-smooth muscle actin, 0.4 μg/ml; fibroblast
surface protein, 0.4 μg/ml; aldo-keto reductase 1
(AKR1C3), 11 μg/ml (Sigma-Aldrich, Poole, UK); ca-
thepsin K, 2.5 μg/ml (Abcam, Cambridge, UK); thromb-
oxane synthase, 8 μg/ml (Proteintech, Manchester, UK);
α8 integrin, 1 μg/ml (Insight Biotechnology, Wembley,
UK). The secondary antibodies and dilutions used were:
polyclonal goat anti-mouse antibody labelled with
alexafluor 488, 1:250; polyclonal goat anti-rabbit anti-
body labelled with rhodamine red-X, 1:250 (both from Invi-
trogen, Paisley, UK). Cell nuclei were stained with DAPI
(1 μg/ml, diluted in PBS) and the cells mounted using
DAKO fluorescent mounting media (Dakocytomation,
Cambridgeshire, UK). Cells were then visualised using 20×
and 40× objective lens on an epifluorescent microscope
(Nikon, Surrey, UK, Diaphot 300 +Hg lamp) by SPOTCam
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Advanced software (Image Solutions, Chorley, Lancashire,
UK). The published images were recorded by applying
background subtraction and keeping a constant exposure
time and gain for each antibody to facilitate qualitative
comparison.
Statistical analyses
For all assays, across group differences were analysed by
two-way ANOVA. Figures represent mean values ± SEM.
Statistical analyses and curve fitting were completed by
using GraphPad Prism v5 (GraphPad, San Diego, CA,
USA); a p-value < 0.05 was considered significant.
Results
Early passage human ASM cells are capable of clonal
expansion and exhibit distinct variations in growth rates
Initial experiments were performed to determine whether
it was possible for single-sorted human ASM cells to sur-
vive and proliferate in culture. Following sorting, each well
was thoroughly examined microscopically to ensure that
no more than one cell was present. Figure 1 shows an
image of cell(s) observed within the same well on days 2, 5
and 18.
Overall a single human ASM cell was detected in 130 of
the 768 wells seeded (16.9%) with the rest of the wells
either demonstrating the presence of more than one hu-
man ASM cell or no cell at all. These were therefore ex-
cluded from all further analyses. Of the 130 cells which
were successfully single-sorted, a total of 76 clones (58%)
expanded sufficiently to quantify doubling times (i.e. at
least achieved confluency in the original well of the 96 well
plate). When doubling times were assessed they were ob-
served to range from 1.1 days to 18.3 days (Figure 2). A
further 54 clones (42% of the wells seeded with single
cells) did not reach confluency over the time course of
each individual experiment (3 months) with the majority
of these undergoing senescence.
Clonally expanded human ASM cell populations exhibit
phenotype heterogeneity
To further explore the heterogeneity of cells within a clonal
population, cells were passaged further (see methods) giv-
ing sufficient numbers for immunocytochemistry and
functional assays to be performed. Here to best investi-
gate the phenotypic range, clonal cell populations were
grouped based on the time required for the clones to
achieve confluency in culture plates in initial experi-
ments (see Figure 2). These were defined as follows: I)
Fast Growing clonal populations: Populations achieving
confluency in a 25 cm2 tissue culture flask in less than
45 days and II) Slow Growing clonal populations: Popu-
lations achieving confluency in a 25 cm2 tissue culture
flask in 45 days or more.
These studies demonstrated expression of the classical
mesenchymal cell phenotypic markers, α-smooth muscle
actin (Figure 3A & C) and fibroblast surface protein
(FSP) (Figure 3E & G) in both slow- and fast-growing
clonal human ASM cell populations. In all cases cells
were serum starved to ensure differences were not cell
cycle dependent. The expression profile of these charac-
teristic markers revealed some qualitative differences
(see Table 1) with counter-intuitively, the slow-growing
populations demonstrating increased levels of FSP and
decreased levels of α- smooth muscle actin when com-
pared with the fast-growing populations. We also inves-
tigated the expression of the novel mesenchymal cell
markers identified in our previous work [11] in these
clonal populations. Aldo-keto reductase 1 C3 (AKR1C3)
expression could not be observed at detectable levels in
either the fast- or slow-growing clonal cell populations
(figure not shown). However, both clonal cell popula-
tions studied expressed cathepsin K (Figure 4A & C),
TBXAS1 (thromboxane synthase 1, Figure 4E & G), and
α8-integrin (Figure 4I & K) with no obvious qualitative
difference in their expression levels or cellular localisa-
tion (see Table 1).
A CB
Figure 1 Clonal expansion of early passage human ASM cells. Early passage human ASM cells were single sorted by fluorescence-activated
cell sorting and subcultured in 20% or 10% FCS containing DMEM medium at 37°C, 5% CO2 atmosphere. All images were taken from the same
well and used ×40 objective (A) Single human ASM cell as seen in culture on day 2 (see black arrow). (B) Single human ASM cell proliferating to
give rise to a number of cells (day 5). (C) Further expansion at day 18.
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Human ASM cell clonal populations show morphological
heterogeneity
Following clonal expansion, and after repeated sub cul-
turing, variations in cellular morphology were observed
within single clonal populations, thus despite all cells
within that population originating from a single cell
(Figure 5A & B, here immunostained to show cathepsin
K expression). Morphological heterogeneity was evident
in the form of elongated-spindle shaped, short-spindle
shaped or broad-elongated cell populations. Such mor-
phological variations were seen in all clonal populations
irrespective of their proliferative potential and are also
evident when cells within the same field are compared
for Figures 3 and 5.
Figure 2 Proliferation rates of clonally expanded early passage human ASM cells. Human ASM cells (passage 2–4) were clonally expanded
following fluorescence-activated cell sorting or dilution cloning techniques and doubling time of clones expanded from single cell human ASM
cultures in four independent experiments was recorded. Data represents the time in which clonal cell populations became confluent over culture
vessels with different surface areas.
C D
G H
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Figure 3 Immunocytochemical expression of standard mesenchymal cell marker. Fast and slow growing clonally expanded human ASM
cell populations were grown on 8-well chamber glass slides to 80% confluency. Following cell fixation, slow and fast growing clonal populations
were immunocytochemically labelled for α-smooth muscle actin (A & C respectively; 0.4 μg/ml; B & D corresponding isotype control) and
fibroblast surface protein (E & G respectively; 0.4 μg/ml; F & H corresponding isotype control). Images were captured with ×20 objective lens
using an epifluorescent microscope with matched exposure time and gains. Images are representative of 3 independent experiments.
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PDGF-stimulation induces significant differences in [3H]
thymidine uptake amongst different human ASM clonal
populations
To further quantify the differences in proliferative capacity
observed in the clonal populations [3H] thymidine uptake
was assessed in response to the potent human ASM cell
mitogen, Platelet-Derived Growth Factor (PDGF) at a con-
centration previously observed to be maximal in terms of
human ASM cell proliferation (20 ng/ml) [17]. Twenty
four hour exposure to PDGF-BB induced a range from
1.19 ± 0.06 to 16.49 ± 4.63 (mean ± SEM) fold increase
over basal in [3H] thymidine incorporation (Figure 6A).
For comparative purposes unsorted donor-matched cells
were grown to the same confluence and used as a bench-
mark “standard” for responses. [3H] thymidine uptake in
human ASMs grown under standard culture conditions (i.
e. not subjected to single cell sorting or clonal expansion)
following stimulation with PDGF (20 ng/ml) for 24 hours
was observed to be 5.74 ± 0.19 (mean ± SEM) fold over
the control.
The average [3H] thymidine uptake observed in all
fast-growing clonal populations in response to PDGF
stimulation (20 ng/ml) for 24 hours was 8.22 ± 2.4 (n =
4, mean ± SEM) fold over control and that observed in
slow-growing clones was 3.27 ± 0.3 (n = 3, mean ± SEM)
fold over control. However this difference was not statis-
tically significant due to the diverse range of inter-clonal
population responses observed even within these groups.
(p = 0.1). Only two clones classified as fast-growing had
a higher [3H] thymidine uptake compared to the stand-
ard. Overall, there was a significant difference in the
Table 1 Immunofluorescence against known phenotypic
markers performed on fast and slow growing clonal
populations
Phenotype markers Slow growing
clonal populations
Fast growing
clonal populations
α-smooth muscle actin ++ +++
Fibroblast surface protein ++ +
Cathepsin K + ++
Thromboxane synthase ++ ++
α8 integrin ++ ++
Staining intensity was categorized into 3 grades (+, low staining; ++, moderate
staining; +++, intense staining) and recorded by blinded observations. Results
represent observations from 3 independent studies.
C D
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Figure 4 Immunocytochemical localization of novel mesenchymal cell markers. Fast and slow growing clonally expanded human ASM cell
populations were grown on 8-well chamber glass slides to 80% confluency. Following cell fixation, slow and fast growing clonal populations were
immunocytochemically labelled for cathepsin K (A & C respectively; 2.5 μg/ml; B & D corresponding isotype control), thromboxane synthase 1
(E & G respectively; 8 μg/ml; F & H corresponding isotype control) and α8 integrin (I & K respectively; 1 μg/ml; J & L corresponding isotype
control). Images were captured with ×20 objective lens using an epifluorescent microscope with matched exposure time and gains. Images are
representative of 3 independent experiments.
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growth rates across all the clones (p < 0.001 by two-way
ANOVA).
Altered Isoproterenol-induced cyclic AMP production in
human ASM clones
In order to examine potential functional heterogeneity
between cell populations expanded from single human
ASM progenitors, we chose to study signaling responses
in two physiologically and clinically important pathways
present in these cells: β2-adrenoceptor mediated signal-
ing constituting the major pro-relaxant pathway in ASM
cells and IP3 production used as a functional readout for
pro-contractile Gq-coupled receptor activation.
First, we investigated cyclic AMP production in all the
cell clones following stimulation with the β-adrenoceptor
agonist, isoproterenol at a range of different concentra-
tions (10 μM to 1 nM). Figure 6B demonstrates the
isoproterenol-induced dose-dependent increase in cyclic
AMP production observed in both clonal populations and
the unsorted, donor-matched “standard” cells. The max-
imum cyclic AMP accumulation observed was recorded
in data from a single Fast Growing clonal population (4.4
± 0.3 fold c.f. basal) in response to exposure to 10 μM
isoproterenol. However this effect was lower compared to
the unsorted, donor-matched ‘standard’ cell response
achieved at the same concentration of isoproterenol (5.4
± 1.12, Figure 6B). The average cyclic AMP production
recorded in all fast-growing clones was 2.8 ± 0.1 (n = 3)
and 2.74 ± 0.18 (n = 3) in all slow-growing clonal cells
on stimulation with 10 μM of isoproterenol. Statistical
analyses by two-way ANOVA demonstrated a significant
difference in cyclic AMP production across all the
clones thus the clones exhibited diverse signalling cap-
acities (p < 0.001). However the variation observed in
cyclic AMP accumulation and hence β2-adrenoceptor-
mediated signaling, does not appear to be related to the
proliferative capacity of the clonal populations.
Altered Gq-coupled receptor signaling in human ASM
clonal populations
To assess pro-contractile Gq-coupled receptor-mediated
signaling, bradykinin and histamine were utilised to in-
duce a concentration-dependent accumulation of [3H]
Inositol Phosphate (IP) in human ASM clonal cell popu-
lations (Figure 6C & D). The highest [3H] IP was pro-
duced by the unsorted, donor-matched ‘standard’ cell
type in response to stimulation with the maximum dose
of the contractile agonists namely bradykinin (10 μM)
(5.16 ± 0.4 fold increase cf vehicle, Figure 6C) and hista-
mine (100 μM) (2.63 ± 0.3 fold increase cf vehicle
Figure 6D). As can be observed in Figure 6C exposure
to bradykinin was observed to induce the maximum ob-
served increase in [3H] IP in the Slow Growing clonal
populations (2.9 ± 0.2 fold increase cf vehicle) compared
to the Fast Growing clones (2.78 ± 0.2 fold increase cf
vehicle). The same trend was observed following hista-
mine stimulation (Figure 6D) with the slow proliferating
clones demonstrating higher levels of [3H] IP (2.17 ±
0.04 fold increase cf vehicle) than the Fast Growing pop-
ulations (1.98 ± 0.2). However these differences were not
statistically significant. Statistical analyses of the data
across all the clones following bradykinin and histamine
stimulation showed a significant difference in the pro-
duction of [3H] IP (p < 0.001 and p = 0.0023 by two-way
ANOVA respectively).
Discussion
This is the first study to examine the clonogenic poten-
tial of human ASM cells. The main objective of this
study was to determine whether different lineages of
A B
Figure 5 Morphological characterisation of early passage human ASM cells following single-cell cloning. Following fluorescence-activated
cell sorting based single-cell sorting, early passage human ASM cells were subjected to clonal expansion and sub cultured in 10% foetal calf
serum supplemented growth media. Their morphological characteristics were observed and recorded in (A) slow-growing clonal populations and
(B) fast-growing clonal populations at passage 7. Cells are labelled for cathepsin K (2.5 μg/ml). Representative images of isotype controls are
shown in Figure 4B & D.
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airway mesenchymal cells can be derived from early pas-
sage cultures of human ASM cells by single-cell cloning.
The next aim was to investigate their morphological,
phenotypic and functional characteristics. Critically, our
studies demonstrate that the majority of single cells
present within early passage human ASM cell cultures
have the potential to create expanded cell populations.
The clonal populations exhibited dramatic differences in
their doubling times ranging from 1.1 to 18.3 days in the
58% of clones which proliferated sufficiently to be quan-
tified. Furthermore morphological and functional het-
erogeneity were also seen to exist within these clonal
populations. These findings confirm the existence of a
heterogeneous group of cells within these cultures which
may have the potential to develop diverse phenotypes
(hypercontractile, contractile or synthetic). Our observa-
tion that the majority of cells isolated from early passage
cultures of human ASM are capable of expansion from a
Figure 6 Altered proliferative and signaling responses in human ASM clonal populations. In all panels each data point represents mean ±
SEM (n = 3). Four Fast Growing clonal populations (•••) and four-five Slow Growing clonal populations (− − −) (as defined in the methods) were
used in addition to the standard (not clonally derived) donor population (─). (A) [3H] thymidine incorporation in human ASM clonal populations
in response to a range of PDGF-BB concentrations (0.00002 ng/ml to 20 ng/ml) or vehicle alone (Veh). Statistical analyses identifies significant
difference in the proliferative response across all the clones (p < 0.001, two-way ANOVA). (B) cAMP formation in clonal human ASM populations
in response to stimulation with varying concentrations of isoproterenol (10 μM to 1 nM) or vehicle alone (Veh). Significant differences were
observed in cAMP formation across all the clonal populations (p < 0.001, two-way ANOVA). (C) [3H] Inositol Phosphate accumulation following
stimulation of human ASM clonal populations with varying concentrations of bradykinin (10 μM to 0.1 nM) or vehicle alone (Veh). Statistical
analyses of the data across all the clones showed a significant difference in the production of tritiated inositol phosphates (p < 0.001, two-way
ANOVA). (D) [3H] Inositol Phosphate accumulation following stimulation of human ASM clonal populations with a range of histamine doses
(100 μM to 1nM) or vehicle alone (Veh). Significant difference was observed in the total inositol phosphate accumulation across all the clonal
groups following statistical analysis (p = 0.0023, two-way ANOVA).
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single isolated cell indicates the presence of large num-
bers of cells with significant proliferative potential in this
cell population.
Functional data from our studies demonstrate varied
proliferative response by different human ASM clones,
both in the absence of mitogens and also following stimu-
lation with PDGF. In our study these clones were classi-
fied into groups based on their doubling time in the
absence of the mitogens. Interestingly, the fast-growing
clones did not only have higher basal proliferation rates
but also exhibited a higher proliferative response following
PDGF stimulation suggesting these cells have an intrinsic
pro-proliferative phenotype.
Based on previously published studies [18-23] we hy-
pothesized that the majority of the cells within the fast-
growing clonal population would be of a “synthetic”
phenotype and the slow-growing clonal populations
would comprise more of the “contractile” forms. Hence
we attempted to look at the phenotype characteristics of
these two different clonal populations by immunocyto-
chemistry. We used a range of previously published
markers [11] to identify human ASM cells (the classical
contractile form) and human airway fibroblasts (the clas-
sical synthetic phenotype). We have previously reported
the overlap between ASM and fibroblasts and from
this study chose to use α-smooth muscle actin, FSP,
cathepsin K, thromboxane synthase and α8 integrin
[11]. Contrary to expectation, the fast growing clonal
population had, if anything, slightly increased levels of
α smooth muscle actin and the slow growing popula-
tions had increased levels of FSP. It is important to
recognise that both the standard culturing conditions
used and the specific conditions required for the different
experiments each have the capacity to promote different
phenotypes. For example culturing with serum (as was
done through the clonal expansion phase of the study)
would be expected to promote the synthetic phenotype
whereas the serum deprivation performed prior to im-
munofluorescent and second messenger studies should
promote an increased proportion of cells exhibiting
contractile characteristics. These experimental condi-
tions are largely unavoidable i.e. attempting to derive
clonal populations from single cells is unlikely to be
successful. Another consideration is how the stiff plas-
tic substrate on which all cells were cultured and on
which experiments were performed itself promotes the
enrichment of certain phenotypes. Whilst it is widely
recognized that extracellular matrix composition alters
ASM phenotype and signaling capabilities [10,20,24], it
is increasingly being recognised that the physical prop-
erties of the substrate alone can also affect phenotype
i.e. static vs dynamic, 2D vs 3D, differential stiffness as
recently reviewed [25]. Whether the expansion of clonal
populations in a more physiological environment would
result in different outcomes to those reported here
is unknown.
The coexistence of cell populations with diverse prolif-
erative responses is key in understanding the relation-
ship between ASM cell heterogeneity and airway
remodeling. It is important to remember that the cells
described in this manuscript represent a population
which has been effectively enriched for proliferative
properties with non-proliferative cells being lost follow-
ing the original isolation of the ASM cells and early
passaging. However, that there remains such cellular
diversity in phenotype from a culture of cells which have
already been through two passages is still perhaps sur-
prising. So what could be the origin of the observed
populations? And why would a clonally-derived popula-
tion of cells exhibit diverse morphological differences in
identical culture conditions? Possible sources of these
highly proliferative populations are mesenchymal stem
cells or progenitor cells such as fibrocytes either from
peripheral blood or from within the tissue [6,15]. To
date it is unclear whether mesenchymal stem cell popu-
lations exist within airway smooth muscle cell bundles
and are able to contribute to the increased smooth
muscle mass observed in asthma [6]. A little more is
understood about lung fibrocytes which are fibroblast-
like progenitor cells first detected outside the circulation
in human bronchial mucosa in patients with chronic
allergic asthma [26]. Intriguingly, fibrocytes exposed to
TGFβ have been observed to become more smooth
muscle-like in phenotype [27]. In addition, levels of fibro-
cytes have been correlated with the yearly decline in lung
function in patients with asthma presenting with chronic
airflow obstruction [27]. Recently the same group reported
an increase in the accumulation of fibrocytes in bronchial
walls of patients with the same clinical phenotype [28].
This is in agreement with the study by Saunders et al.,
where elevated number of fibrocytes were observed in
the ASM bundles of individuals with asthma compared
with controls, however there was no correlation between
this and lung function [29]. Another possible source
of myofibroblasts into the airways is via epithelial-
mesenchymal transitions, however emerging evidence
from lineage-tracing studies raises the possibility that
the latter may just be a consequence of in vitro culture
and not occur in vivo [30].
It is however important to note that the cultures used
for the experiments we describe here were derived from
nonasthmatic human airways and hence would be unlikely
to contain fibrocyte-derived populations if such cells only
traffic to the lung following airway inflammation.
It was interesting to note that the proliferative po-
tential of each clonal population did not appear to in-
fluence either (pro-relaxant) cyclic AMP-mediated or
(pro-contractile) IP3-mediated signaling, especially when
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considered with the observation that cells with an in-
creased proliferative rate exhibited increased α-smooth
muscle actin and decreased FSP expression. These data
suggest that it is perhaps not feasible to dichotomize the
ASM populations into “good” (anti-proliferative, anti-
contractile, pro-relaxant) and “bad” (being the opposite)
as might have been assumed from previous studies where
a proliferative, synthetic phenotype is associated with re-
duced contractile protein [18-23]. However, as evidenced
by the diverse morphology observed within clonal popula-
tions (which we did not address quantitatively), there
are subpopulations of cells within the clonal populations
which are quite different. So whilst we observed differ-
ences between the clonal populations, it would be re-
vealing to understand how subpopulations within these
further differ, particularly in terms of GPCR density or sig-
naling capacity. Seminal studies in this field from Halayko
and colleagues using canine tracheal smooth muscle
cells both characterized subpopulations which arose
after prolonged serum deprivation [31]. Here one sixth
of the cells were observed to exhibit a contractile pheno-
type as characterized by elongated morphology, alignment
into bundles, increased expression of smooth muscle
α-actin, smooth muscle myosin heavy chain and SM22
and, importantly, expression of muscarinic M3 receptors
which are usually lost from smooth muscle cells through
culturing [31]. Thus whether subpopulations within the
clonal populations exhibited diverse GPCR expression re-
mains to be explored.
Conclusions
In summary, we have shown that human ASM cell cul-
tures represent heterogeneous cell populations that ex-
hibit morphological and functional differences. Our
studies also reveal that a significant proportion of individ-
ual early passage human ASM cells have the potential to
create expanded cell populations suggesting the presence
of large number of mesenchymal progenitors. Taken to-
gether we suggest that these phenotypically diverse cell
populations existing within ASM cultures may contribute
differentially to inflammatory and remodelling processes
within the airways.
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